Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 4/20 | 0.64 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.64 |
| ▸ | P2RY10 | O00398 | 6/20 | 0.54 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.51 |
| ▸ | S1PR2 | O95136 | 4/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.48 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.47 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dexfosfoserine SCHEMBL28634379 | 0.92 | P2RY10 (0.66) | LPAR1LPAR3P2RY10S1PR1GPR34 | |
| Serine SCHEMBL27750376 | 0.90 | LPAR1 (0.71) | LPAR1LPAR3P2RY10LPAR5S1PR2 | |
| Serine SCHEMBL27997070 | 0.89 | LPAR1 (0.74) | LPAR1LPAR3P2RY10LPAR5S1PR2 | |
| Serine SCHEMBL28869167 | 0.89 | LPAR1 (0.74) | LPAR1LPAR3P2RY10LPAR5S1PR2 | |
| SCHEMBL26642945 | 0.88 | P2RY10 (0.58) | P2RY10GPR34 | |
| SCHEMBL1534116 | 0.88 | P2RY10 (0.58) | P2RY10GPR34 | |
| SCHEMBL609831 | 0.85 | P2RY10 (0.65) | LPAR1LPAR3P2RY10LPAR2GPR34 | |
| SCHEMBL29238665 | 0.85 | P2RY10 (0.65) | LPAR1LPAR3P2RY10LPAR2GPR34 | |
| Serine SCHEMBL27966438 | 0.84 | LPAR1 (0.66) | LPAR1LPAR3P2RY10LPAR5LPAR2 | |
| SCHEMBL8694073 | 0.84 | P2RY10 (0.60) | P2RY10GPR34 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113365607-A | Lipid vesicles for oral drug delivery | 豪夫迈·罗氏有限公司 | 2021-09-07 | — | — | CN | disclosed |